Trinity Biotech (TRIB) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart Transcripts

Trinity Biotech Revenue Highlights

Latest Revenue (Y)

$56.83M

Latest Revenue (Q)

$14.70M

Main Segment (Y)

Point-of-Care

Main Geography (Y)

America

Trinity Biotech Revenue by Period

Trinity Biotech Revenue by Year

Date	Revenue	Change
2023-12-31	$56.83M	-24.00%
2022-12-31	$74.78M	-19.56%
2021-12-31	$92.97M	-8.84%
2020-12-31	$101.98M	12.77%
2019-12-31	$90.44M	-6.80%
2018-12-31	$97.03M	-2.12%
2017-12-31	$99.14M	-0.47%
2016-12-31	$99.61M	-0.58%
2015-12-31	$100.19M	-4.46%
2014-12-31	$104.87M	14.97%
2013-12-31	$91.22M	10.55%
2012-12-31	$82.51M	5.85%
2011-12-31	$77.95M	-13.04%
2010-12-31	$89.64M	-28.81%
2009-12-31	$125.91M	-10.16%
2008-12-31	$140.14M	-2.42%
2007-12-31	$143.62M	21.02%
2006-12-31	$118.67M	20.41%
2005-12-31	$98.56M	23.29%
2004-12-31	$79.94M	21.73%
2003-12-31	$65.68M	26.35%
2002-12-31	$51.98M	40.24%
2001-12-31	$37.06M	24.62%
2000-12-31	$29.74M	13.94%
1999-12-31	$26.10M	12.52%
1998-12-31	$23.20M	38.10%
1997-12-31	$16.80M	133.33%
1996-12-31	$7.20M	-27.27%
1995-12-31	$9.90M	90.38%
1994-12-31	$5.20M	116.67%
1994-02-28	$2.40M	-

Trinity Biotech generated $56.83M in revenue during NA 2023, up -24.00% compared to the previous quarter, and up 58.57% compared to the same period a year ago.

Trinity Biotech Revenue by Quarter

Date	Revenue	Change
2024-03-31	$14.70M	9.50%
2023-12-31	$13.43M	-8.51%
2023-09-30	$14.68M	5.61%
2023-06-30	$13.90M	-6.28%
2023-03-31	$14.83M	-17.78%
2022-12-31	$18.04M	-7.52%
2022-09-30	$19.50M	5.62%
2022-06-30	$18.46M	-1.66%
2022-03-31	$18.78M	-3.84%
2021-12-31	$19.52M	-11.27%
2021-09-30	$22.00M	-14.86%
2021-06-30	$25.84M	0.97%
2021-03-31	$25.59M	-21.89%
2020-12-31	$32.77M	2.35%
2020-09-30	$32.01M	99.79%
2020-06-30	$16.02M	-24.33%
2020-03-31	$21.18M	-0.66%
2019-12-31	$21.32M	-13.32%
2019-09-30	$24.59M	9.32%
2019-06-30	$22.50M	2.14%
2019-03-31	$22.03M	-10.19%
2018-12-31	$24.52M	3.42%
2018-09-30	$23.71M	-5.16%
2018-06-30	$25.00M	5.05%
2018-03-31	$23.80M	-3.07%
2017-12-31	$24.55M	-4.11%
2017-09-30	$25.60M	0.61%
2017-06-30	$25.45M	8.12%
2017-03-31	$23.54M	-0.61%
2016-12-31	$23.68M	-9.36%
2016-09-30	$26.13M	-0.61%
2016-06-30	$26.29M	11.79%
2016-03-31	$23.52M	-5.70%
2015-12-31	$24.94M	-3.20%
2015-09-30	$25.76M	6.20%
2015-06-30	$24.26M	-3.89%
2015-03-31	$25.24M	-5.40%
2014-12-31	$26.68M	-1.77%
2014-09-30	$27.16M	4.45%
2014-06-30	$26.00M	3.92%
2014-03-31	$25.02M	-1.69%
2013-12-31	$25.45M	5.53%
2013-09-30	$24.12M	13.18%
2013-06-30	$21.31M	4.84%
2013-03-31	$20.33M	-2.38%
2012-12-31	$20.82M	-0.13%
2012-09-30	$20.85M	0.20%
2012-06-30	$20.81M	3.91%
2012-03-31	$20.03M	0.06%
2011-12-31	$20.01M	0.94%
2011-09-30	$19.83M	1.91%
2011-06-30	$19.45M	4.29%
2011-03-31	$18.65M	-3.08%
2010-12-31	$19.25M	2.66%
2010-09-30	$18.75M	-17.14%
2010-06-30	$22.63M	-22.01%
2010-03-31	$29.01M	-5.78%
2009-12-31	$30.79M	-2.87%
2009-09-30	$31.70M	-1.85%
2009-06-30	$32.30M	3.84%
2009-03-31	$31.11M	-8.54%
2008-12-31	$34.01M	-4.42%
2008-09-30	$35.58M	-1.97%
2008-06-30	$36.30M	5.96%
2008-03-31	$34.25M	100.00%
2007-12-31	-	-

Trinity Biotech generated $14.70M in revenue during Q1 2024, up 9.50% compared to the previous quarter, and up 81.53% compared to the same period a year ago.

Trinity Biotech Revenue Breakdown

Trinity Biotech Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Point-of-Care	$9.09M	$9.21M	$10.34M	$9.21M	$11.39M
Clinical laboratory services	-	-	$7.93M	$8.48M	-
Clinical laboratory goods	-	-	$74.70M	$84.28M	-
Clinical laboratory	-	-	-	-	$68.13M
Laboratory services	-	-	-	-	$10.91M

Trinity Biotech's latest annual revenue breakdown by segment (product or service), as of Dec 23: Point-of-Care (100.00%).

Quarterly Revenue by Product

Product/Service	Jun 22
Clinical Laboratory	$29.53M
Laboratory Services	$3.70M

Trinity Biotech's latest quarterly revenue breakdown by segment (product or service), as of Jun 22: Clinical Laboratory (88.86%), and Laboratory Services (11.14%).

Trinity Biotech Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
America	$32.28M	$40.18M	-	-	-
Ireland	$12.72M	$28.23M	-	-	-
Americas	-	-	$57.80M	$70.41M	$52.18M
Clinical laboratory services	-	-	$7.93M	-	-
Clinical laboratory goods	-	-	$74.70M	-	-
Asia / Africa	-	-	$25.50M	$22.57M	$27.69M
Point-of-Care	-	-	$10.34M	-	-
Other Countries	-	-	-	-	-
Europe (including Ireland)	-	-	-	$9.01M	$10.57M

Trinity Biotech's latest annual revenue breakdown by geography, as of Dec 23: America (71.73%), and Ireland (28.27%).

Quarterly Revenue by Country

Country	Jun 22
Clinical Laboratory	$29.53M
Laboratory Services	$3.70M

Trinity Biotech's latest quarterly revenue breakdown by geography, as of Jun 22: Clinical Laboratory (88.86%), and Laboratory Services (11.14%).

Trinity Biotech Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
FONR	FONAR	$102.88B	$25.94M
SHC	Sotera Health Company	$1.05B	$285.47M
GTH	Genetron	$650.71M	$201.32M
NOTV	Inotiv	$572.42M	$105.79M
CSTL	Castle Biosciences	$219.79M	$85.78M
OLK	Olink AB (publ)	$169.91M	$28.59M
LAB	Standard BioTools	$106.34M	$44.97M
STIM	Neuronetics	$71.35M	$16.45M
MDXH	MDxHealth SA	$70.19M	$19.83M
TRIB	Trinity Biotech	$56.83M	$14.70M
XGN	Exagen	$52.55M	$15.06M
BDSX	Biodesix	$49.09M	$18.15M
ACRS	Aclaris Therapeutics	$31.25M	$4.35M
PRE	Prenetics Global	$21.74M	$6.41M
SERA	Sera Prognostics	$306.00K	$24.00K
NDRA	ENDRA Life Sciences	-	-

TRIB Revenue FAQ

What is Trinity Biotech’s yearly revenue?

Trinity Biotech's yearly revenue for 2023 was $56.83M, representing a decrease of -24.00% compared to 2022. The company's yearly revenue for 2022 was $74.78M, representing a decrease of -19.56% compared to 2021. TRIB's yearly revenue for 2021 was $92.96M, representing a decrease of -8.84% compared to 2020.

What is Trinity Biotech’s quarterly revenue?

Trinity Biotech's quarterly revenue for Q1 2024 was $14.7M, a 9.50% increase from the previous quarter (Q4 2023), and a -0.84% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $13.43M, a -8.51% decrease from the previous quarter (Q3 2023), and a -25.55% decrease year-over-year (Q4 2022). TRIB's quarterly revenue for Q3 2023 was $14.68M, a 5.61% increase from the previous quarter (Q2 2023), and a -24.74% decrease year-over-year (Q3 2022).

What is Trinity Biotech’s revenue growth rate?

Trinity Biotech's revenue growth rate for the last 3 years (2021-2023) was -38.87%, and for the last 5 years (2019-2023) was -37.16%.

What are Trinity Biotech’s revenue streams?

Trinity Biotech's revenue streams in c 23 are Point-of-Care

What is Trinity Biotech’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Trinity Biotech was Point-of-Care. This segment made a revenue of $9.09M, representing 100.00% of the company's total revenue.